Miao Liu

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Bioinformatics Analysis

Coronavirus Disease

Top Venues

Journal of medical virology

Cancer management and research

Cancer control : journal of the Moffitt Cancer Center

Technology in cancer research & treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Liyang Zhao, Yusi Li, Wenjuan Yi, Kuo Yan, Chao Yang, Sridhar Radhakrishnan, Rui Li, Ruirong Tan, Gang Fan, Mengyuan Dai, Miao Liu, Ning-Yi Shao
Reply to Chan, et al. Journal of medical virology (2022)
Meng-Yuan Dai, Yu-Ying Shi, An-Jin Wang, Xue-Lian Liu, Miao Liu, Hong-Bing Cai
High-potency PD-1/PD-L1 degradation induced by Peptide-PROTAC in human cancer cells. Cell death & disease 13 (11) (2022)
Liyang Zhao, Yusi Li, Wenjuan Yi, Kuo Yan, Chao Yang, Sridhar Radhakrishnan, Rui Li, Ruirong Tan, Gang Fan, Mengyuan Dai, Miao Liu, Ning-Yi Shao
The clinical and bioinformatics analysis for the role of antihypertension drugs on mortality among patients with hypertension hospitalized with COVID-19. Journal of medical virology 94 (10) (2022)
Mengyuan Dai, Sridhar Radhakrishnan, Rui Li, Ruirong Tan, Kuo Yan, Gang Fan, Miao Liu
Targeted Protein Degradation: An Important Tool for Drug Discovery for "Undruggable" Tumor Transcription Factors. Technology in cancer research & treatment 21 (2022)
Yan Leng, Ming Chen, Mengyuan Dai, Yang Wu, Shao-Qing Lei, Kuo Yan, Ning-Yi Shao, Zhongyuan Xia, Miao Liu
Minimized glycemic fluctuation decreases the risk of severe illness and death in patients with COVID-19. Journal of medical virology 93 (7) (2021)
Meng-Yuan Dai, Zhen Chen, Yan Leng, Meng Wu, Yu Liu, Fuxiang Zhou, Chen Ming, Ningyi Shao, Miao Liu, Hongbing Cai
Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China. Cancer control : journal of the Moffitt Cancer Center 27 (1) (2020)
Wen-Jie Huang, Shuai Ruan, Fang Wen, Xiao-Na Lu, Su-Ping Gu, Xiao-Xue Chen, Miao Liu, Peng Shu
Multidrug Resistance of Gastric Cancer: The Mechanisms and Chinese Medicine Reversal Agents. Cancer management and research 12 (2020)